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Marco AE Marcus1,4, Wolfgang F Buhre1 and Hans-Fritz Gramke1Abstract
We hypothesized that improved acute postoperative pain relief will be achieved using general anaesthesia (GA) either
in combination with continuous thoracic paravertebral block (GA-cPVB) or single shot (GA-sPVB) as compared to GA
supplemented by local wound infiltration (GA-LWI) after unilateral major breast cancer surgery.
A randomised controlled trial was conducted in 46 adult women in a day-care or short-stay hospital setting after major
breast cancer surgery. Pain-intensity was measured using an 11-point visual analogue scale (VAS) until postoperative
day 2. GA-sPVB was stopped due to slow inclusion.
No significant difference in VAS score was noted between GA-LWI (VAS median 0.5 (interquartile range 0.18–2.00)) and
GA-cPVB, (VAS 0.3 (0.00–1.55, p = 0.195)) 24 hours after surgery or at any point postoperatively until postoperative day 2.
We conclude that both GA-LWI and GA-cPVB anaesthetic techniques are equally effective in treatment of acute
postoperative pain after major oncological breast surgery. As GA-LWI is easily to perform with fewer complications
and it is more cost-effective it should be preferred over GA-cPVB.
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Optimal acute postoperative pain relief after major surgical
breast surgery is still a matter of debate. After major
oncological breast surgery patients still suffer from
acute postoperative pain. Data of our own patient
population (Sommer et al. 2008) showed that 22% of
the patients reported mean VAS of >40 (of a scale 0–100)
on the first postoperative day after major breast surgery.
This was confirmed in a recent cohort study with a re-
ported mean pain score of 3.82 (SD 2,47) on the postopera-
tive day 1 (Gerbershagen et al. 2013; Gerbershagen et al.
2014). In this context, a paravertebral block (PVB) which
provides a unilateral segmental nerve block is advo-
cated as the technique of choice for breast surgery
(PROSPECT working group 2008). Previous studies ob-
served improved acute postoperative pain management* Correspondence: esther.bouman@mumc.nl
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2000; Naja et al. 2003; Terheggen et al. 2002), less nausea
(Kairaluoma et al. 2004; Klein et al. 2000; Naja et al.
2003), faster recovery from anaesthesia (Kairaluoma
et al. 2004), earlier hospital discharge (Naja et al. 2003),
and reduced incidence of chronic postoperative pain
when PVB is used (Kairaluoma et al. 2006). The lower
incidence of postoperative nausea and vomiting (PONV)
and the faster recovery makes PVB an attractive analgesic
approach to day care surgery, as a significant amount of
the surgical procedures are currently performed in this
setting (in the Netherlands 51% (Statistics Netherlands
(CBS) 2012)). The majority of studies only compared
general anaesthesia (GA) with PVB and systemic pain
therapy with the use of intravenous opioids. However, in
daily practice local wound infiltration (LWI) with local an-
aesthetics is commonly used complementary to systemic
analgesics for postoperative pain relief (Johansson et al.
2003; Sidiropoulou et al. 2008; Vigneau et al. 2011). There-
fore, the use of GA with PVB (GA-PVB) should be com-
pared to GA with LWI (GA-LWI).an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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analgesic effects of a GA combined with PVB as compared
to GA with LWI in patients undergoing major breast
surgery in day or short stay hospital setting. We hypothe-
sised that better acute postoperative pain relief 24 hours
after surgery (Day 1) could be achieved using GA-PVB as
compared to GA-LWI.
Methods
This study was carried out in compliance with the Helsinki
Declaration. Following approval by the medical ethics com-
mitee of Maastricht University Medical Center+ (reference
number MEC 05-105), written informed consent and regis-
tration at www.clinicaltrials.gov identifier: NCT00547989,
patients were included in a prospective, open, randomised
controlled trial. The study population consisted of adult
women scheduled for one-sided, major breast cancer
surgery. Surgical procedures included wide local exci-
sion (WLI), mastectomy and modified radical mastectomy
(MRM). Sentinel node procedure, axillary dissection, or
immediate prosthetic breast reconstruction was mandatory
in case of WLI and optional in case of mastectomy or
MRM.
All patients were ASA class I or II and planned for day
care or short stay surgery. Exclusion criteria were as follows:
contra-indication for regional anaesthesia, coagulation
disorders, infection at point of insertion, infection in
thoracic cavity, tumour in paravertebral area, history of
pleurectomy, and history of allergic reaction to contrast
medium or local anaesthetics.
Patients were randomised in two phases, using a
computer generated list. First, patients were assigned
to GA plus local wound infiltration (GA-LWI) or GA
plus PVB (GA-PVB). Secondly, patients in the PVB
group were then randomised either in a subgroup with
single shot PVB (GA-sPVB)) or in a subgroup with
continuous PVB (GA-cPVB) using a paravertebral
catheter and patient controlled analgesia.
Patients in groups GA-sPVB and GA-cPVB received a
thoracic paravertebral block preoperatively according
to a standard technique described in detail elsewhere
(Terheggen et al. 2002; Eason & Wyatt 1979). A member of
the study group (either EB or HG) performed all proce-
dures. Briefly, a 20 Gauge catheter (B.Braun Melsungen AG,
Melsungen, Germany) was inserted 3 cm into the paraver-
tebral space at thoracic level 3–4, using an 18 Gauge Tuohy
cannula needle. After a test dose of 3 ml ropivacaine 0.75%,
a total dose of 0.25 ml/kg ropivacaine 0.75% was injected.
Postoperatively, the position of the catheter was confirmed
by thoracic X-ray and injection of 2–3 ml contrast medium
(Iohexol 240 mg l/ml, Omnipaque® GE Healthcare B.V. The
Netherlands) via the catheter.
Induction of GA was performed with propofol 2–3 mg/kg
and sufentanil 0.1-0.2 μg/kg at induction, rocuronium0.6 mg/kg to facilitate endotracheal intubation or laryngeal
mask airway. Maintenance of anaesthesia was performed
according to hospital practice in general with sevoflurane/
air (0.9-1.3 MAC) and additional boluses of sufentanil as
clinically deemed necessary.
Surgery was performed by or under close supervision
of a dedicated staff surgeon.
Patients in group GA-cPVB received continuous infusion
of ropivacaine 0.2% at 5 ml/h plus an optional patient
controlled bolus of 5 ml (lock-out interval: one hour)
(Easypump® RA 400–5 PCA, B. Braun Melsungen AG,
Melsungen, Germany). Adjunct postoperative analgesia in
all groups consisted of paracetamol (4 × 1000 mg)
fixed dose and a non-steroidal anti-inflammatory drug
(NSAID) (naproxen or diclofenac) in combination with pir-
itramide and ondansetron as required. Day care patients
were allowed to stay overnight in case of delayed recovery.
Patient baseline characteristics age, length, weight,
ASA classification, and surgical data were recorded. At the
PACU, vital signs on arrival and nausea (Numeric Rating
Scale, NRS 0–10) were registered. The primary outcome
measure, postoperative pain, was measured using a visual
analogue scale ranging from 0 to 10 (VAS). A pain score of
less than 4 on the VAS was considered as sufficient for
postoperative analgesia (Jensen et al. 2003). Postoperative
pain was measured on arrival at the PACU, on discharge
from the PACU, and from then on three times per day
(at 8.00-14.00-20.00 hr.) for two postoperative days. After
discharge from the PACU the patients used a pain diary to
record the pain scores. In addition, patients were asked to
report the use of analgesics as well as the overall satisfaction
with pain treatment (5-point-verbal rating scale). Initially a
GA-sPVB patient group was planned and included in
which the paravertebral catheter was removed at the PACU
after an additional dose of 10 ml ropivacaine 0.2%.
However, due to very low inclusion rate of patients in the
GA-sPVB group the Medical Ethical Committee suggested
to stop the inclusion of patients into this group.
Patients in group GA-LWI received local wound
infiltration with10 ml bupivacaine 0.25% before wound
closure according to the standard procedure for extended
mamma surgery as used in our hospital (MUMC+, the
Netherlands).
In order to o detect a 1.5 (SD 1.5) VAS pain score
difference at 24 hours after surgery (Kairaluoma et al. 2004)
with a power of 80% and a significance level of 5%,
our analysis revealed that 16 patients needed to be
included per group. Assuming a drop-out of 10%, we
decided to include 18 patients per group.
Baseline data and secondary outcomes were analysed
using student’s t-test and Fisher Exact Tests for parametric
data, Mann Whitney U-tests for non-parametric data, and
Chi-square tests for categorical data. Multivariate analysis
of the primary VAS score outcome was performed using a
Bouman et al. SpringerPlus 2014, 3:517 Page 3 of 8
http://www.springerplus.com/content/3/1/517multilevel linear model. Differences between GA-LWI and
GA-cPVB as a function of time were assessed with the
intervention and time as fixed effects. Interaction between
treatment group and time was assessed.
Adjustment for covariates, age, ASA-classification, peri-
operative opioid use, and type of surgery was entered in
the model. For the primary outcome measure, substitution
of missing data was not performed as the multilevel linear
model is sufficiently robust in handling missing data.
All data were analysed according to the intention to
treat principle, using the Statistical Package for the Social
Sciences (SPSS® version 18, Chicago, Illinois, USA). A
p value < 0.05 was considered statistically significant.Assessed f
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Figure 1 Consort flow chart. GA-LWI: general anaesthesia and local wound
block, GA-cPVB: general anaesthesia and continuous PVB.Results
Trial recruitment was scheduled from October 2006 to
April 2011. A total of 449 patients were screened. The
proportion of eligible patients was 53% (238) of whom
19% (46) gave informed consent (Figure 1). An interim
analysis was performed in October 2009. Due to low in-
clusion rate it was decided to exclude the GA-sPVB
group from analysis. The present analysis is therefore
based on a total of 36 patients: GA-cPVB (n = 18) and
GA-LWI (n = 18). No relevant significant differences
were noted between groups with regard to baseline
characteristics or type of surgery (Table 1). Patients in
the GA-LWI group received significantly more opioidsor eligibility (n= 449)
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Logistical reasons (n= 17)
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Age (years) 57.9 (13.8) 60.9 (12.7) 0.52
Length (cm) 166.7 (6.9) 165.6 (4.2) 0.55
Weight (kg) 70.8 (17.5) 67.4 (9.43) 0.47
ASA I/II 9 / 9 5 / 13 0.17
Airway TT/LMA 11/7 10/8 0.74
Total dose sufentanil (μg) 33.1(10.6) 25.1(9.5) 0.024
Intraoperative infusion (ml) 1194 (300) 1428(379) 0.048
Duration of anaesthesia (hours) 2.50(0.69) 2.57(0.66) 0.78
Duration of surgery (hours) 1.98(0.61) 2.09(0.58) 0.58




Ablatio/MRM + Axillary node 3 6
Ablatio/MRM + Plastic surgery +/−
Axillary node
3 5
GA-LWI: general anaesthesia and local wound infiltration, GA-cPVB general
anaesthesia and continuous PVB, TT: tracheal tube; LMA: laryngeal mask airway.
MRM: modified radical mastectomy. Values are numbers or mean (SD).
Figure 2 Postoperative pain scores. Values are VAS pain, median IQR. PA
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(Table 1).
There was no significant difference in the primary
outcome parameter VAS score between GA-LWI
(VAS median 0.5 (0.18–2.00)) and GA-cPVB, (VAS
median 0.3 (0.00–1.55, p = 0.195)) 24 hours after surgery.
No difference in VAS score between GA-LWI and
GA-cPVB was noted at any time point postoperatively
until postoperative day 2 (Figure 2).
Moreover, no significant differences between GA-LWI
and GA-cPVB were noted in the number of patients that
used opioids on the day of surgery, although the amount
of opioids used was significantly lower in GA-cPVB as
compared to GA-LWI (Table 2). This difference in the
amount of opioids per patient was not associated with a
difference in the incidence of postoperative nausea or
the need for anti-emetic drugs in the PACU. Patient
satisfaction questionnaire revealed equal results in
GA-LWI and GA-cPVB (Table 2).
The placement of the paravertebral catheter was suc-
cessful in all patients. A vascular puncture occurred in
one patient. The median indwelling time from start of
surgery was 43.3 (IQR 41.7-46.3) hours.
Analysis of the course of pain on postoperative Days 1
and 2 using the multilevel linear model with VAS pain
score as a function of time (hours) as the dependentCU: post anaesthetic care unit.
Table 2 PONV, postoperative opioid use and satisfaction with analgesic treatment
GA-LWI n = 18 GA-cPVB n = 18 p value
PACU Nausea at discharge 0.9(1.4) 1.0(1.5) 0.82
PACU anti-emetic use (yes/no/missing) 13/4/1 14/4/0 1.00
Opioid use day 0 (yes/no/missing) 7/10/1 6/12/0 0.63
Piritramide day 0 (mg) 7.5 (0–26) 1.5 (0–8) 0.03
Satisfaction with treatment 0.87
Bad - Moderate 0 1
Good 2 2
Very good - Excellent 13 14
missing 3 1
GA-LWI: general anaesthesia and local wound infiltration; GA-cPVB: general anaesthesia and continuous paravertebral block. Values are numbers, mean (SD), or
mean (range).
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did not differ between GA-cPVB and GA-LWI.
The postoperative time course (hours) and the inter-
action between intervention and time were significant
predictors of postoperative VAS-pain score in both
GA-LWI and GA-cPVB (Table 3).
Initially, VAS-pain score decreased rapidly; thereafter a
slight decrease in pain intensity was observed which
lasted several hours, for both groups (Figure 2). The
average reduction of 0.5 on VAS at postoperative day 1
is attributed to continuous paravertebral block using
PCA. Assessment of potential confounding factors like
age, ASA classification, and type of surgery did not reveal
significant effects (Table 1).
Thoracic X-ray confirmed the correct position of the
paravertebral catheter and revealed no pneumothorax.
The contrast medium mainly spread along the thoracic
paravertebral space (n = 11) a cloud like pattern (n = 3) an
intercostal spread (n = 2) or a combination of paravertebral
and intercostal spread (n = 2) (Figure 3).Table 3 Multilevel analysis parameter estimates of fixed
effects





GA-cPVB −0.283 −1.287 0.721 0.57
Time after surgery −0.052 −0.064 −0.039 0.000
GA-cPVB* Time −0.023 −0.041 −0.005 0.012
Age 0.081 −0.027 0.043 0.64
ASA −0.223 −1.073 0.628 0.60
Additional axillary dissection 0.184 −0.847 1.215 0.72
Additional immediate prosthetic
breast reconstruction
0.715 −0.522 1.952 0.25
Total dose sufentanil 0.130 −0.030 0.056 0.54
GA-cPVB: general anaesthesia and continuous paravertebral block, cPVB *
Time: interaction effect between intervention and time after surgery.We observed only minor complications after GA-cPVB:
minor bleeding at the puncture site in one patient,
premature catheter dislocation in another patient.
Furthermore, three patients complained about back
pain, and one patient was not capable of pushing the
PCA button.
Discussion
The results of the present study suggest that general
anaesthesia combined with local wound infiltration
(GA-LWI) and continuous paravertebral infusion of local
anaesthetics (GA-cPVB) are equally effective in acute
postoperative pain relief. Patients receiving GA-cPVB
used a significantly lower amount of systemic opioids as
compared to patients in GA-LWI group. The increased
amount of systemic opioids was, however, not associated
with an increased incidence of postoperative PONV in
group GA-LWI.
In the present study, correct placement of the paraver-
tebral catheter was confirmed via chest X-Ray after sur-
gery. Furthermore, PVB was performed by two members
of the study team (EB, HG), in a standardised manner that
contributed to the high success rate of the technique. A
basic analgesic regimen was prescribed for all patients and
surgery was performed by or under close supervision of a
dedicated staff surgeon.
The main limitation of our study was the slow inclusion
rate and a low proportion of screened patients suitable for
randomisation, as earlier reported (Buckenmaier et al.
2010). Another limitation might be the fact that the
study was not performed in a blinded fashion. In this
context it is important to note that due to the potentials
risk of the PVB procedure and the eventual burden for
study participants, sham PVB was not considered an
option.
Relatively low pain scores were noted in both GA-LWI
and GA-cPVB groups on postoperative day 1. These low
pain scores, in particular in the GA-LWI group, were not
expected as a previous study of our group (Sommer et al.
Figure 3 Examples radiographic contrast medium spread in patients with continuous paravertebral block. a. radiographic contrast
medium spread in thoracic paravertebral space. b. Intercostal spread of radiographic contrast medium.
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at rest >40 (scale 0–100) on the first postoperative day
(Sommer et al. 2008).
The combination of assistance of an oncological sup-
port team (mamma-care nurse), a dedicated study team
and a motivated patient group may have been contrib-
uted to these low pain scores at postoperative day 1.
Moreover all patients received a basic analgesic regimen
including paracetamol (4 × 1000 mg) fixed dose and a
non-steroidal anti-inflammatory drug (NSAID) (naproxen
or diclofenac) in combination with piritramide and ondan-
setron as required.
Median and worst pain scores in patients undergo-
ing different surgical procedures were analysed re-
cently in two cohort studies (Gerbershagen et al. 2013;
Gerbershagen et al. 2014). In the subgroup of patients
undergoing breast surgery, mean numeric rating scale
(NRS) was 3.26 and 2.98 for major and minor breast sur-
gery, respectively. These cohort studies did not present
detailed information on the use of PVB or LWI nor is
there information provided on the pain scores 24 hours
after surgery (Gerbershagen et al. 2013; Gerbershagen
et al. 2014). Nevertheless, we conclude that patients in our
study showed postoperative VAS scores comparable to
those reported for the general population undergoing this
type of surgery. Moreover, three RCTs addressed the same
issues. Continuous wound infiltration was compared with
single injection paravertebral block and low absolute post-
operative VAS-pain scores in both groups up to 24 hours
after surgery was reported (Sidiropoulou et al. 2008).
These results are in line with the present study where ab-
solute postoperative VAS-pain scores in both GA-cPVB
and GA-LWI groups were low and were comparable be-
tween the groups. It should be stressed that in the study
of Sidiropoulou (Sidiropoulou et al. 2008) both groups re-
ceived more systemic opioids after surgery than patients
from the present study. Systemic opioid use is commonly
associated with an increased incidence of nausea andvomiting (Miaskowski 2009) a finding that, however, can-
not be supported by the results of the present study.
The results of the present study and those presented
by Sidiropoulou (Sidiropoulou et al. 2008) differ from a
number of studies in which GA alone and GA-PVB were
compared. For instance, no difference between groups
was found when effects of single shot PVB alone, com-
bined with continuous PVB and placebo was studied in
74 patients undergoing breast surgery (Buckenmaier
et al. 2010). The latter study includes, however, some
major limitations. Not only the PVB technique used was
a mixture of a single shot and a multilevel approach, also
the assignment of patients to the 3 groups was stratified
by surgery class, and patients were deeply sedated during
the procedure and conversion to GA was necessary in
12% of the patients. Furthermore 21 patients with incom-
plete data were excluded from the analysis (Buckenmaier
et al. 2010).
Most recently, an interesting randomised controlled
study (Abdallah et al. 2014) was published which com-
pared multilevel PVB/total intravenous anaesthesia
(TIVA) and a balanced volatile anaesthetic technique.
Here lower pain scores and improved recovery scores
were reported in the PVB/TIVA group as well as a re-
duced incidence of nausea and vomiting. Comparison
with the data from our study is difficult as study designs
considerably differ. In the study of Abdallah (Abdallah
et al. 2014) patients in the volatile general anaesthesia
group also received nitrous oxide, whereas patients in
the TIVA group received propofol and oxygen in air.
Both, volatile anaesthetics and nitrous oxide can contrib-
ute to the increased incidence of nausea and vomiting
and can, at least in part, explain the lower recovery
scores in the general volatile anaesthesia group as noted
in this study (Abdallah et al. 2014). Even more import-
ant, the patients received no local wound infiltration and
no basic analgesic regimen. Interestingly, median pain
scores in the PVB group (Abdallah et al. 2014) were
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tients met the discharge criteria from the PACU, suggest-
ing that LWI, cPVB and multilevel single shot PVB are
comparable with respect to peri-operative pain scores.
In a large observational single institution study pa-
tients with breast surgery not undergoing early recon-
structive surgery, no differences in nausea, vomiting and
postoperative pain scores were observed (Aufforth et al.
2012). However hospital charts of patients were retro-
spectively analysed.
The efficacy and safety of paravertebral blocks in
breast surgery was calculated based on a meta-analysis
of randomised clinical trials (Schnabel et al. 2010). In
this meta-analysis, 15 RCTs were included with a total
of 877 patients. Then significant differences in pain
scores in the initial period (<2 h) as well as up to
48 hours for both the combination of PVB and general
anaesthesia vs. GA alone were reported (Schnabel et al.
2010). The observation that the funnel plot showed
asymmetry might be of significant importance and sug-
gests publications bias regarding negative study results.
Although the direct postoperative VAS scores at PACU
arrival in our study were somewhat higher, we noted
that VAS values dropped consistently in both GA-cPVB
and GA-LWI groups. From this we may conclude that
LWI is a cost effective and low risk procedure and seems
to be comparable to the PVB approach.
The results of our study are encouraging as LWI is
easy, readily available and has almost no side effects. It
is less invasive than other regional techniques like para-
vertebral and interpleural blocks (Kundra et al. 2013)
and there is no need for any technical device or follow
up for catheter removal. From our study we tentatively
conclude that in contrast with more painful procedures
the wearing off of local anaesthetic effect after wound
infiltration is not a major determinant for pain during
the next days.
We have demonstrated that both GA-LWI and GA-
cPVB techniques were effective in treatment of acute
postoperative pain after major oncological breast sur-
gery. As GA-LWI is easily to perform with fewer com-
plications and it is more cost-effective it should be
preferred over GA-cPVB. A possible additional value of
continuous paravertebral block in more painful extended
procedures has to be investigated.
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